)
Visual
test
Poly Medicure
Poly Medicure (531768) investor relations material
Poly Medicure Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary7 Mar, 2026
Platform overview and global reach
Operates in 125+ countries with 15 manufacturing plants across 5 countries and a 1.8 billion+ annual device capacity.
Holds 390+ patents and has 950+ distributors and 570+ sales associates globally.
Largest exporter of consumable medical devices for 10 consecutive years.
Innovation, R&D, and product pipeline
100+ R&D professionals and 30+ new product launches annually, with 100+ products in the development pipeline.
390+ patents granted, with strong in-house tooling, automation, and rapid prototyping capabilities.
Plans to double R&D spending in the coming years.
Strategic acquisitions and portfolio expansion
Acquired Plan Health, Pendracare, and Citieffe, expanding into cardiology and orthopaedics.
Post-acquisition, Plan Health grew at 20% CAGR with improved margins; Citieffe and Pendracare added significant revenue and EBITDA.
Focused on expanding trauma, cardiology, and orthopaedics portfolios, including new launches and clinical trials.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Poly Medicure
- Double-digit revenue growth and margin strength driven by expansion and innovation.531768
Q3 25/266 Feb 2026 - Q3 FY25 revenue up 24.9% YoY, margins and cash position strong, growth outlook robust.531768Q3 24/253 Feb 2026
- Q1 revenue and EBITDA up 20%, EPS rises, exports surge, and capacity expansion drives growth.531768Q1 24/253 Feb 2026
- H1 FY25 saw 23% revenue growth, 28.06% EBITDA margin, and robust QIP-driven expansion.531768Q2 24/2518 Jan 2026
- FY25 revenue rose 21.5% with margin gains, QIP capital raised, and a ₹3.50 dividend recommended.531768Q4 24/257 Jan 2026
- Q1 FY26 delivered strong revenue and profit growth, led by domestic momentum and innovation.531768Q1 25/266 Jan 2026
- FY26 guidance revised to 15%-16% growth, strong margins, and major European acquisitions.531768Q2 25/2610 Nov 2025
- Acquisition accelerates global orthopaedics expansion with strong product and market synergies.531768M&A Announcement25 Sep 2025
- Acquisition of a European cardiology consumables group accelerates global expansion and synergies.531768M&A Announcement4 Sep 2025
Next Poly Medicure earnings date
Q4 25/267 May, 2026
Poly Medicure
Next Poly Medicure earnings date
Q4 25/267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage